Therapy of Acute Myeloid Leukemia

    January 2012 in “ InTech eBooks
    Jean El‐Cheikh, Roberto Crocchiolo
    Studysummary In this study, higher doses of daunorubicin during induction therapy significantly improved complete remission rates in young adults with acute myeloid leukemia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →